TARGETING ANEURYSM DISEASE BY MODULATING PHAGOCYTOSIS PATHWAYS

摘要

In the methods of the invention, an agent that increases phagocytosis and/or efferocytosis of cellular components of coronary plaque is administered to the subject in a dose and for a period of time effective to stabilize, prevent or reduce aneurysm disease in the individual.